NASDAQ:CMPX

Compass Therapeutics Stock News

Healthcare > Biotechnology

Buy CMPX

*Your capital is at risk

$2.10

+0.0200 (+0.96%)

At Close: Jun 03, 2026

CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

12:07pm, Friday, 08'th Oct 2021

BOSTON & SEONGNAM, S. Korea & SHANGHAI/SUZHOU, China--(BUSINESS WIRE)-- #AACR--CTX-009 (ABL001/ES104) clinical data presented today at the New Drugs on the Horizon plenary session of 2021 AACR-NCI-EOR

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by